Zymeworks Inc. Common Stock (ZYME) earnings · rev $106.0M
These earnings events as JSON? API free 100/dayZymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
This ZYME earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ZYME revenue for 2025-12-31 was $106.0M. Net income was -$81.1M. Revenue was up 38.9% from 2024-12-31 to 2025-12-31. ZYME currently screens at market cap $1.68B.
When the next ZYME 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 38.9% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full ZYME research stays on the stock page; the tape stays on the quote page.
ZYME earnings FAQ
What are ZYME's latest revenue and net income?
Latest cached Zymeworks Inc. Common Stock (ZYME) revenue for Dec 31, 2025 was $106.0M. Net income was -$81.1M. Statements: https://lician.com/financials/zyme
What is ZYME's latest diluted EPS?
Latest cached Zymeworks Inc. Common Stock (ZYME) diluted EPS for Dec 31, 2025 was -$1.08.
What period does the latest ZYME earnings print cover?
The latest cached Zymeworks Inc. Common Stock (ZYME) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did ZYME revenue change from the prior cached period?
Cached Zymeworks Inc. Common Stock (ZYME) revenue was up 38.9% from $76.3M (Dec 31, 2024) to $106.0M (Dec 31, 2025). Statements: https://lician.com/financials/zyme
Where are ZYME earnings listed?
Cached earnings facts for Zymeworks Inc. Common Stock (ZYME) are listed at https://lician.com/earnings/zyme. Statements: https://lician.com/financials/zyme
Not investment advice.